ASN 2025
6 - 9 November 2025
Kidney, cardiovascular, and death outcomes with semaglutide treatment among two race and two ethnic groups: post hoc analysis from the FLOW trial
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.